Hiya, sorry but I don't know. No agreement details have been released and AT1 hadn't sold enough to disclose Ag numbers vs revenue in FY21 (eg: we know 50k Ab tests were sold but not how many Ag)
Speculating, yes, $1-$3 seems reasonable to me if the volume price will be $10-$15 (as Access Bio would retain the larger share as manufacturer, brand packaging etc and AT1 would have local sale, regulatory and shipping costs to cover).
I have asked the Q in the Coffee MicroCaps presentation (on currently) so will post if it gets answered shortly.
